• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    FDA Approval for CORTROSYN issued to AMPHASTAR PHARMS INC

    12/27/23 4:38:39 AM ET
    $AMPH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AMPH alert in real time by email
    New Drug Application (NDA): 016750
    Company: AMPHASTAR PHARMS INC
    • Email

    Products on NDA 016750

    Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
    CORTROSYN COSYNTROPIN 0.25MG/VIAL INJECTABLE;INJECTION Prescription AP Yes Yes

    Approval Date(s) and History, Letters, Labels, Reviews for NDA 016750

    Original Approvals or Tentative Approvals
    Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
    04/22/1970 ORIG-1 Approval Type 1 - New Molecular Entity STANDARD

    Label is not available on this site.

    Supplements
    Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
    12/22/2023 SUPPL-33 Labeling-Package Insert

    Label is not available on this site.

    12/14/2021 SUPPL-32 Labeling-Container/Carton Labels, Labeling-Package Insert Label (PDF)
    Letter (PDF)
    https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016750Orig1s032lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/016750Orig1s032ltr.pdf
    09/29/2014 SUPPL-28 Manufacturing (CMC)

    Label is not available on this site.

    11/05/2002 SUPPL-18 Labeling Letter (PDF)

    Label is not available on this site.

    https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/16750slr018ltr.pdf
    12/07/2000 SUPPL-17 Manufacturing (CMC)-Control

    Label is not available on this site.

    03/18/1999 SUPPL-16 Manufacturing (CMC)-Control

    Label is not available on this site.

    01/09/1998 SUPPL-15 Labeling

    Label is not available on this site.

    01/29/1997 SUPPL-14 Manufacturing (CMC)

    Label is not available on this site.

    04/08/1997 SUPPL-13 Manufacturing (CMC)-Control

    Label is not available on this site.

    02/18/1994 SUPPL-12 Manufacturing (CMC)

    Label is not available on this site.

    04/28/1989 SUPPL-10 Labeling

    Label is not available on this site.

    10/28/1988 SUPPL-9 Manufacturing (CMC)

    Label is not available on this site.

    05/09/1988 SUPPL-8 Manufacturing (CMC)-Control

    Label is not available on this site.

    02/26/1987 SUPPL-7 Manufacturing (CMC)-Control

    Label is not available on this site.

    05/08/1987 SUPPL-6 Manufacturing (CMC)-Control

    Label is not available on this site.

    02/10/1987 SUPPL-5 Manufacturing (CMC)-Control

    Label is not available on this site.

    04/02/1986 SUPPL-4 Labeling

    Label is not available on this site.

    10/26/1982 SUPPL-3 Manufacturing (CMC)

    Label is not available on this site.

    04/28/1982 SUPPL-2 Manufacturing (CMC)-Control

    Label is not available on this site.

    Labels for NDA 016750

    Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
    Patient Package Insert
    Note Url
    12/14/2021 SUPPL-32 Labeling-Container/Carton Labels Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016750Orig1s032lbl.pdf
    12/14/2021 SUPPL-32 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016750Orig1s032lbl.pdf

    Therapeutic Equivalents for NDA 016750

    CORTROSYN

    INJECTABLE;INJECTION; 0.25MG/VIAL
    TE Code = AP

    Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
    CORTROSYN COSYNTROPIN 0.25MG/VIAL INJECTABLE;INJECTION Prescription Yes AP 016750 AMPHASTAR PHARMS INC
    COSYNTROPIN COSYNTROPIN 0.25MG/VIAL INJECTABLE;INJECTION Prescription No AP 090574 MYLAN INSTITUTIONAL
    COSYNTROPIN COSYNTROPIN 0.25MG/VIAL INJECTABLE;INJECTION Prescription No AP 202147 SANDOZ
    Get the next $AMPH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AMPH

    DatePrice TargetRatingAnalyst
    5/12/2025$30.00Overweight → Neutral
    Analyst
    2/4/2025$66.00 → $36.00Overweight → Neutral
    Piper Sandler
    11/22/2024$55.00Equal Weight
    Wells Fargo
    3/5/2024$60.00Overweight
    JP Morgan
    11/17/2023$63.00Neutral
    BofA Securities
    7/25/2023$70.00Buy
    Jefferies
    10/21/2022$36.00Buy
    Jefferies
    7/29/2022$44.00Overweight
    CapitalOne
    More analyst ratings

    $AMPH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • FDA Approval for MEDROXYPROGESTERONE ACETATE issued to AMPHASTAR PHARMS INC

      Submission status for AMPHASTAR PHARMS INC's drug MEDROXYPROGESTERONE ACETATE (SUPPL-5) with active ingredient MEDROXYPROGESTERONE ACETATE has changed to 'Approval' on 01/25/2024. Application Category: ANDA, Application Number: 077334, Application Classification: Labeling

      1/26/24 4:40:02 AM ET
      $AMPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • FDA Approval for CORTROSYN issued to AMPHASTAR PHARMS INC

      Submission status for AMPHASTAR PHARMS INC's drug CORTROSYN (SUPPL-33) with active ingredient COSYNTROPIN has changed to 'Approval' on 12/22/2023. Application Category: NDA, Application Number: 016750, Application Classification: Labeling

      12/27/23 4:38:39 AM ET
      $AMPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • FDA Approval for NALOXONE HYDROCHLORIDE issued to AMPHASTAR PHARMS INC

      Submission status for AMPHASTAR PHARMS INC's drug NALOXONE HYDROCHLORIDE (SUPPL-1) with active ingredient NALOXONE HYDROCHLORIDE has changed to 'Approval' on 06/29/2023. Application Category: NDA, Application Number: 208969, Application Classification: Labeling

      6/30/23 9:33:25 AM ET
      $AMPH
      Biotechnology: Pharmaceutical Preparations
      Health Care